Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-1-24
pubmed:abstractText
The requirement for co-stimulation in T-cell activation has become firmly established, whilst the precise identity of the molecules involved remains uncertain. Some of the major co-stimulatory molecules include ICAM-1, LFA-3 and B7. We have investigated the abilities of both LFA-3 and B7 to co-stimulate T-cell proliferation under a number of conditions using transfected Chinese hamster ovary cells. Using anti-CD3 antibodies we observed that B7 but not LFA-3 transfectants were capable of co-stimulating proliferation in purified peripheral blood T cells. In addition, both LFA-3 and B7 could induce proliferation in response to phytohaemagglutinin (PHA) and we obtained additive effects using both B7 and LFA-3 together. Using the superantigen staphylococcal enterotoxin B (SEB), we observed that presentation to purified T cells required the presence of class II-positive transfectants and that sensitivity to antigen was increased approximately 100-fold by the co-transfection of either B7 or LFA-3. However, when co-stimulatory molecules were provided by cells separate from those engaging the T-cell receptor (TcR), only B7 was capable of enhancing proliferation. Kinetic studies which investigated the time dependence for co-stimulation revealed that T cells responding to anti-CD3 antibodies required the B7 co-stimulation within the first few hours, for proliferation to be effective. Our data differentiate between the co-stimulatory abilities of B7 and LFA-3 and support the concept of a pivotal role for B7 in T-cell proliferation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1349172, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1355602, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1372649, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1377404, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1378854, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1380180, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1383383, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1650475, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1692079, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1713678, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1716521, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1847722, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1847724, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1848579, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1907921, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-1972160, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2113314, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2147950, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2162180, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2540528, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2576417, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2653373, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2834436, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-2964908, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-3029267, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-3143077, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-6274961, http://linkedlifedata.com/resource/pubmed/commentcorrection/7505258-7678229
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
242-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
pubmed:affiliation
Bath Institute for Rheumatic Diseases, Trim Bridge, U.K.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't